Bai Hua - Net Worth and Insider Trading

Bai Hua Net Worth

The estimated net worth of Bai Hua is at least $142,920 dollars as of 2024-09-28. Bai Hua is the Director of Zhejiang Hisun Pharmaceutical Co Ltd and owns about 18,000 shares of Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) stock worth over $142,920. Details can be seen in Bai Hua's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bai Hua has not made any transactions after 2015-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bai Hua

To

Bai Hua Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bai Hua owns 1 companies in total, including Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) .

Click here to see the complete history of Bai Hua’s form 4 insider trades.

Insider Ownership Summary of Bai Hua

Ticker Comapny Transaction Date Type of Owner
SHSE:600267 Zhejiang Hisun Pharmaceutical Co Ltd 2015-09-25 Director

Bai Hua Latest Holdings Summary

Bai Hua currently owns a total of 1 stock. Bai Hua owns 18,000 shares of Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) as of September 25, 2015, with a value of $142,920.

Latest Holdings of Bai Hua

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600267 Zhejiang Hisun Pharmaceutical Co Ltd 2015-09-25 18,000 7.94 142,920

Holding Weightings of Bai Hua


Bai Hua Form 4 Trading Tracker

According to the SEC Form 4 filings, Bai Hua has made a total of 0 transactions in Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) over the past 5 years. The most-recent trade in Zhejiang Hisun Pharmaceutical Co Ltd is the acquisition of 18,000 shares on September 25, 2015, which cost Bai Hua around $207,774.

Insider Trading History of Bai Hua

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bai Hua Trading Performance

GuruFocus tracks the stock performance after each of Bai Hua's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bai Hua is 42.16%. GuruFocus also compares Bai Hua's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bai Hua within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bai Hua's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bai Hua

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.8 LIMIT LIMIT LIMIT LIMIT LIMIT

Bai Hua Ownership Network

Ownership Network List of Bai Hua

No Data

Ownership Network Relation of Bai Hua

Insider Network Chart

Bai Hua Owned Company Details

What does Zhejiang Hisun Pharmaceutical Co Ltd do?

Who are the key executives at Zhejiang Hisun Pharmaceutical Co Ltd?

Bai Hua is the Director of Zhejiang Hisun Pharmaceutical Co Ltd. Other key executives at Zhejiang Hisun Pharmaceutical Co Ltd include Supervisors Yu Shun Bing , senior management Jin Hong Shun , and senior management Lu Xing Hai .

Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zhejiang Hisun Pharmaceutical Co Ltd Insider Transactions

No Available Data

Bai Hua Mailing Address

Above is the net worth, insider trading, and ownership report for Bai Hua. Currently GuruFocus does not have mailing address information for Bai Hua.

Discussions on Bai Hua

No discussions yet.